• Je něco špatně v tomto záznamu ?

Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction

M. Domanský, M. Andrlík, S. Kurucz, J. Vilimovský, SA. Salih, D. Šimánková, J. Kubeš

. 2024 ; 14 (-) : 100631. [pub] 20240926

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002044

PURPOSE: Despite advancements in radiation techniques, concerns persist regarding the adverse effects of radiation therapy, particularly cardiotoxicity or radiation-induced heart disease. Recently, arrhythmogenic toxicity has come to the forefront-the impact of radiation therapy on the cardiac conduction system. Our objective was to conduct a dosimetric study and subsequently investigate the feasibility of optimizing the sinoatrial (SA) and atrioventricular (AV) nodes as organs at risk (OARs) in proton radiation therapy for non-small cell lung cancer with N3 disease. PATIENTS AND METHODS: Thirty-two non-small cell lung cancer patients with N3 disease undergoing proton radiation therapy were included. Sinoatrial and AV nodes, along with standard OARs, were delineated. Dosimetric analysis and optimization were performed using intensity-modulated proton therapy. RESULTS: Patients surpassing a predefined SA node dose threshold underwent dose optimization. Proton radiation therapy with pencil beam scanning demonstrated a significant reduction in SA and AV node doses without compromising target volume coverage or significant shift in the dose to other monitored OARs. CONCLUSION: Dose reduction to the SA and AV nodes for pencil beam scanning is a relatively simple task, and the reduction can be very substantial. Larger cohort studies and diverse radiotherapeutic modalities are needed for further validation and refinement of dose constraints.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002044
003      
CZ-PrNML
005      
20250123102029.0
007      
ta
008      
250117e20240926xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpt.2024.100631 $2 doi
035    __
$a (PubMed)39399817
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Domanský, Martin $u Proton Therapy Center Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
245    10
$a Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction / $c M. Domanský, M. Andrlík, S. Kurucz, J. Vilimovský, SA. Salih, D. Šimánková, J. Kubeš
520    9_
$a PURPOSE: Despite advancements in radiation techniques, concerns persist regarding the adverse effects of radiation therapy, particularly cardiotoxicity or radiation-induced heart disease. Recently, arrhythmogenic toxicity has come to the forefront-the impact of radiation therapy on the cardiac conduction system. Our objective was to conduct a dosimetric study and subsequently investigate the feasibility of optimizing the sinoatrial (SA) and atrioventricular (AV) nodes as organs at risk (OARs) in proton radiation therapy for non-small cell lung cancer with N3 disease. PATIENTS AND METHODS: Thirty-two non-small cell lung cancer patients with N3 disease undergoing proton radiation therapy were included. Sinoatrial and AV nodes, along with standard OARs, were delineated. Dosimetric analysis and optimization were performed using intensity-modulated proton therapy. RESULTS: Patients surpassing a predefined SA node dose threshold underwent dose optimization. Proton radiation therapy with pencil beam scanning demonstrated a significant reduction in SA and AV node doses without compromising target volume coverage or significant shift in the dose to other monitored OARs. CONCLUSION: Dose reduction to the SA and AV nodes for pencil beam scanning is a relatively simple task, and the reduction can be very substantial. Larger cohort studies and diverse radiotherapeutic modalities are needed for further validation and refinement of dose constraints.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Andrlík, Michal $u Proton Therapy Center Czech, Prague, Czech Republic
700    1_
$a Kurucz, Samuel $u Proton Therapy Center Czech, Prague, Czech Republic
700    1_
$a Vilimovský, Jan $u Proton Therapy Center Czech, Prague, Czech Republic
700    1_
$a Salih, Sarah Al-Hamami $u Proton Therapy Center Czech, Prague, Czech Republic
700    1_
$a Šimánková, Daniela $u Institute of Nuclear Medicine, First Medical Faculty Charles University, General University Hospital Prague, Prague, Czech Republic
700    1_
$a Kubeš, Jiří $u Proton Therapy Center Czech, Prague, Czech Republic
773    0_
$w MED00215028 $t International journal of particle therapy $x 2331-5180 $g Roč. 14 (20240926), s. 100631
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39399817 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123102023 $b ABA008
999    __
$a ok $b bmc $g 2254459 $s 1238047
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 14 $c - $d 100631 $e 20240926 $i 2331-5180 $m International journal of particle therapy $n Int J Part Ther $x MED00215028
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...